ClinConnect ClinConnect Logo
Search / Trial NCT03479528

The Predictive Value of Alarm Symptoms in Patients With Dyspepsia Based on Roman IV

Launched by SECOND AFFILIATED HOSPITAL OF XI'AN JIAOTONG UNIVERSITY · Mar 24, 2018

Trial Information

Current as of May 13, 2025

Unknown status

Keywords

Dyspepsia,Alarm Symptoms,Roman Iv

ClinConnect Summary

Functional dyspepsia is one of the most common gastrointestinal disorders (FGIDs) encountered in clinical practice. Functional dyspepsia is a clinical syndrome characterized by chronic and recurrent gastroduodenal symptoms in the absence of any organic or metabolic disease that is likely to explain the symptoms.Functional dyspepsia has a high incidence in the population.Clinical diagnosis is notoriously unreliable in diagnosing the underlying cause of dyspepsia,but a number of alarm features have been suggested as indicating patients at higher risk for serious disease.However, previous stud...

Gender

ALL

Eligibility criteria

  • Inclusion criteria:
  • 1. Aged 18 years and older;
  • 2. Presence of dyspeptic symptoms according with Rome IV criteria (Discomfort was characterized by the presence of one or more symptoms that included bothersome postprandial fullness, bothersome early satiation, bothersome epigastric pain, bothersome epigastric burning, Symptoms had to be present for at least 3 months within the preceding 6 months);
  • 3. From March 2018 to January 2019, patient went to the Gastroenterology clinics of the second affiliated hospital of xi'an jiaotong university, Xijing Hospital, Tangdu Hospital, Xi'an No.3 Hospital, and received gastroscopy;
  • 4. Upper abdominal ultrasonography, blood routine examination, liver function test were conducted within six months.
  • Exclusion criteria:
  • 1. History of esophagitis or ulcer disease or other organic upper gastrointestinal disease, pancreaticobiliary disease, metabolic disease(abnormal thyroid function, diabetes );
  • 2. Were pregnant, might become pregnant, or were lactating;
  • 3. Major abdominal surgery;
  • 4. Severe neurological disorder, psychological diseases; or with severe hepatic, renal or respiratory dysfunction;
  • 5. Known or suspected liver dysfunction, including NASH, HBV or HCV-related hepatitis;
  • 6. History of gastroscope within 1 year;
  • (6) Current antidepressant, steroids or NSAID use; (7) Patients who had only reflux-related symptoms or who had predominantly reflux-related symptoms; (8) Not willing to participate in the study.

About Second Affiliated Hospital Of Xi'an Jiaotong University

The Second Affiliated Hospital of Xi'an Jiaotong University is a leading medical institution in China, dedicated to advancing healthcare through innovative clinical research and patient care. Affiliated with one of the country's premier universities, the hospital combines clinical excellence with academic rigor, fostering a multidisciplinary approach to healthcare challenges. With a strong emphasis on patient-centered care, the hospital engages in a wide range of clinical trials aimed at improving treatment outcomes and enhancing medical knowledge. Its commitment to ethical standards and regulatory compliance ensures that all research initiatives prioritize patient safety and scientific integrity.

Locations

Xi'an, Shanxi, China

Patients applied

0 patients applied

Trial Officials

Jinhai Wang, MD

Study Director

The Second Affiliated Hospital of Xi'an Jiaotong University,Xi'an, Shaanxi, China

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials